Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview

Kang Liang Zeng, Chia-Lin Tseng, Hany Soliman, Yonatan Weiss, Arjun Sahgal, Sten Myrehaug, Kang Liang Zeng, Chia-Lin Tseng, Hany Soliman, Yonatan Weiss, Arjun Sahgal, Sten Myrehaug

Abstract

The oligometastatic state is hypothesized to represent an intermediary state of cancer between widely metastatic disease and curable, localized disease. Advancements in radiotherapy have allowed for delivery of high precision, dose escalated treatment known as stereotactic body radiotherapy (SBRT) to targets throughout the body with excellent rates of local control. Recently, the first phase II randomized trial comparing conventional radiotherapy to comprehensive SBRT of oligometastatic disease demonstrated an overall survival and progression free survival advantage. The spine is a common site of metastasis, and a complex site for SBRT given the adjacent spinal cord and the tumor embedded within the bone tissue putting the patient at risk of fracture. Although there are expert spine SBRT guidelines for practice, there are as yet no reported randomized trials that proves superiority as compared to conventional radiation. The use of SBRT in patients with oligometastatic disease and spinal metastases is the focus of this review.

Keywords: oligometastases; outcomes; response assessment; spine metastases; stereotactic body radiotherapy (SBRT); toxicities.

Figures

Figure 1
Figure 1
A case presentation of a lady with invasive ductal carcinoma of the breast who was treated definitively with lumpectomy, adjuvant chemotherapy, and adjuvant radiotherapy. Shortly after completion of therapy, on re-staging investigations, she was found to have oligometastatic disease in the bones, specifically at C4, T3, T10, the left sacral ala, and right scapula. She received SBRT to each site and was started on hormonal therapy. At most recent follow-up 20 months later, she has not had progression of known disease nor interval development on new metastatic disease. (a) Posterior-anterior projection of pre-treatment bone scan demonstrating increased uptake within the right scapula, T3 and the right sacral ala. Subsequent images of axial slice of T2-weighted MRI demonstrating near complete marrow replacement of C4 (b), focal marrow abnormality in posterior T3 body (c), rounded focus centrally of the T10 vertebral body (d), and 13 mm lesion of left sacral ala (e).
Figure 2
Figure 2
A man with oligometastatic castrate-resistant prostate cancer with painful spine metastases. This man was treated to 24 Gy in 2 fractions. (a) Axial planning CT scan demonstrating T6 vertebral level with gross tumor volume (GTV), clinical target volume (CTV), and planning target volume (PTV) delineated with red, green, and blue lines, respectively. (b) Sagittal planning CT demonstrating T6 vertebral level with GTV, CTV, and PTV in red, green, and blue, respectively. (c) Dose distribution at the level of T6 with PTV (colorwash blue) and spinal cord planning organ at risk volume (PRV) in colorwash green. Demonstration of sharp-dose fall-off to respect critical structures while allowing coverage of the target volumes.

References

    1. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol Off J Am Soc Clin Oncol. (1995) 13:8–10.
    1. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol Off J Am Soc Clin Oncol. (1994) 12:2229–34.
    1. Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. . Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. (1997) 113:37–49.
    1. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. . Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer. (1996) 77:1254–62.
    1. Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, et al. . Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. (2012) 366:925–31. 10.1056/NEJMoa1112824.
    1. Palma DA, Olson R, Harrow S, et al. . Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. (2019). [Epub ahead of print]. 10.1016/S0140-6736(18)32487-5
    1. Gomez DR, Blumenschein GR, Lee JJ, Hernandez M, Ye R, Camidge DR, et al. . Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. (2016) 17:1672–82. 10.1016/S1470-2045(16)30532-0
    1. Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, et al. . Consolidative radiotherapy for limited metastatic non–small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol. (2018) 4:e173501. 10.1001/jamaoncol.2017.3501
    1. Nguyen J, Chow E, Zeng L, Zhang L, Culleton S, Holden L, et al. . Palliative response and functional interference outcomes using the Brief Pain Inventory for spinal bony metastases treated with conventional radiotherapy. Clin Oncol. (2011) 23:485–91. 10.1016/j.clon.2011.01.507
    1. Tseng C-L, Soliman H, Myrehaug S, Lee YK, Ruschin M, Atenafu EG, et al. . Imaging-based outcomes for 24 Gy in 2 Daily fractions for patients with de novo spinal metastases treated with spine Stereotactic Body Radiation Therapy (SBRT). Int J Radiat Oncol Biol Phys. (2018) 102:499–507. 10.1016/j.ijrobp.2018.06.047
    1. Azad TD, Esparza R, Chaudhary N, Chang SD. Stereotactic radiosurgery for metastasis to the craniovertebral junction preserves spine stability and offers symptomatic relief. J Neurosurg Spine. (2016) 24:241–7. 10.3171/2015.6.SPINE15190
    1. Anand AK, Venkadamanickam G, Punnakal AU, Walia BS, Kumar A, Bansal AK, et al. Hypofractionated stereotactic body radiotherapy in spinal metastasis - with or without epidural extension. Clin Oncol. (2015) 27:345–52. 10.1016/j.clon.2015.01.035
    1. Bishop AJ, Tao R, Rebueno NC, Christensen EN, Allen PK, Wang XA, et al. . Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence. Int J Radiat Oncol Biol Phys. (2015) 92:1016–26. 10.1016/j.ijrobp.2015.03.037
    1. Sellin JN, Reichardt W, Bishop AJ, Suki D, Rhines LD, Settle SH, et al. . Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma. J Neurosurg Spine. (2015) 22:52–9. 10.3171/2014.9.SPINE1482
    1. Bate BG, Khan NR, Kimball BY, Gabrick K, Weaver J. Stereotactic radiosurgery for spinal metastases with or without separation surgery. J Neurosurg Spine. (2015) 22:409–15. 10.3171/2014.10.SPINE14252.
    1. Sohn S, Chung CK, Sohn MJ, Chang U-K, Kim SH, Kim J, et al. . Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study. J Neurooncol. (2014) 119:121–8. 10.1007/s11060-014-1455-9
    1. Guckenberger M, Mantel F, Gerszten PC, Flickinger JC, Sahgal A, Létourneau D, et al. . Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis. Radiat Oncol Lond Engl. (2014) 9:226. 10.1186/s13014-014-0226-2
    1. Thibault I, Al-Omair A, Masucci GL, Masson-Côté L, Lochray F, Korol R, et al. . Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture. J Neurosurg Spine. (2014) 21:711–8. 10.3171/2014.7.SPINE13895
    1. Garg AK, Shiu AS, Yang J, Wang X-S, Allen P, Brown BW, et al. . Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer. (2012) 118:5069–77. 10.1002/cncr.27530
    1. Chang U-K, Cho W-I, Kim M-S, Cho CK, Lee DH, Rhee CH. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group. Acta Oncol Stockh Swed. (2012) 51:589–95.
    1. Gill B, Oermann E, Ju A, Suy S, Yu X, Rabin J, et al. . Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach. Front Oncol. (2012) 2:39. 10.3389/fonc.2012.00039
    1. Wang XS, Rhines LD, Shiu AS, Yang JN, Selek U, Gning I, et al. . Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol. (2012) 13:395–402. 10.1016/S1470-2045(11)70384-9
    1. Staehler M, Haseke N, Nuhn P, Tüllmann C, Karl A, Siebels M, et al. . Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma. BJU Int. (2011) 108:673–8. 10.1111/j.1464-410X.2010.09895.x
    1. Sahgal A, Ames C, Chou D, Ma L, Huang K, Xu W, et al. . Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys. (2009) 74:723–31. 10.1016/j.ijrobp.2008.09.020
    1. Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, et al. . High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys. (2008) 71:484–90. 10.1016/j.ijrobp.2007.11.046
    1. Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, et al. . Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. (2007) 7:151–60. 10.3171/SPI-07/08/151
    1. Gerszten PC, Burton SA, Welch WC, Brufsky AM, Lembersky BC, Ozhasoglu C, et al. . Single-fraction radiosurgery for the treatment of spinal breast metastases. Cancer. (2005) 104:2244–54. 10.1002/cncr.21467
    1. Ryu S, Rock J, Rosenblum M, Kim JH. Patterns of failure after single-dose radiosurgery for spinal metastasis. J Neurosurg. (2004) 101(Suppl. 3):402–5. 10.1016/j.rpor.2015.03.004
    1. Ost P, Jereczek-Fossa BA, As NV, Zilli T, Muacevic A, Olivier K, et al. . Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence: a multi-institutional analysis. Eur Urol. (2016) 69:9–12. 10.1016/j.eururo.2015.07.004
    1. Barzilai O, Versteeg AL, Sahgal A, Rhines LD, Bilsky MH, Sciubba DM, et al. . Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: a multicenter, international study. Cancer. (2018) 125:770–8. 10.1002/cncr.31870
    1. Sahgal A, Roberge D, Schellenberg D, Purdie TG, Swaminath A, Pantarotto J, et al. . The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin Oncol. (2012) 24:629–39. 10.1016/j.clon.2012.04.006
    1. Sahgal A, Larson DA, Chang EL. Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys. (2008) 71:652–65. 10.1016/j.ijrobp.2008.02.060
    1. Expert Panel on Radiation Oncology-Bone Metastases. Lo SS-M, Lutz ST, Chang EL, Galanopoulos N, Howell DD, et al. . ACR Appropriateness Criteria® spinal bone metastases. J Palliat Med. (2013) 16:9–19. 10.1089/jpm.2012.0376
    1. Spratt DE, Beeler WH, de Moraes FY, Rhines LD, Gemmete JJ, Chaudhary N, et al. . An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. Lancet Oncol. (2017) 18:e720–30. 10.1016/S1470-2045(17)30612-5
    1. Laufer I, Rubin DG, Lis E, Cox BW, Stubblefield MD, Yamada Y, et al. . The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. (2013) 18:744–51. 10.1634/theoncologist.2012-0293
    1. Nasrallah H, Yamada Y, Laufer I, Bilsky MH. A NOMS framework solution. Int J Radiat Oncol Biol Phys. (2019) 103:17–8. 10.1016/j.ijrobp.2018.09.026
    1. Tang C, Hess K, Bishop AJ, Pan HY, Christensen EN, Yang JN, et al. . Creation of a prognostic index for spine metastasis to stratify survival in patients treated with spinal stereotactic radiosurgery: secondary analysis of mature prospective trials. Int J Radiat Oncol. (2015) 93:118–25. 10.1016/j.ijrobp.2015.04.050
    1. Rich SE, Chow R, Raman S, Liang Zeng K, Lutz S, Lam H, et al. . Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radiother Oncol J Eur Soc Ther Radiol Oncol. (2018) 126:547–57. 10.1016/j.radonc.2018.01.003
    1. Jensen G, Tang C, Hess KR, Bishop AJ, Pan HY, Li J, et al. . Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery. J Radiosurg SBRT. (2017) 5:25–34. 10.1016/j.ijrobp.2017.02.085
    1. Katagiri H, Takahashi M, Inagaki J, Kobayashi H, Sugiura H, Yamamura S, et al. . Clinical results of nonsurgical treatment for spinal metastases. Int J Radiat Oncol Biol Phys. (1998) 42:1127–32.
    1. Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys. (1995) 32:959–67.
    1. Nguyen Q-N, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, et al. . Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. (2010) 76:1185–92. 10.1016/j.ijrobp.2009.03.062
    1. Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH, et al. . Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol Off J Am Soc Clin Oncol. (2011) 29:3072–7. 10.1200/JCO.2010.34.3897
    1. Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, et al. . A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine. (2010) 35:E1221–9. 10.1097/BRS.0b013e3181e16ae2
    1. Fisher CG, Schouten R, Versteeg AL, Boriani S, Varga PP, Rhines LD, et al. . Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases. Radiat Oncol Lond Engl. (2014) 9:69. 10.1186/1748-717X-9-69
    1. Bilsky MH, Laufer I, Fourney DR, Groff M, Schmidt MH, Varga PP, et al. . Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine. (2010) 13:324–8. 10.3171/2010.3.SPINE09459
    1. Laufer I, Iorgulescu JB, Chapman T, Lis E, Shi W, Zhang Z, et al. . Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine. (2013) 18:207–14. 10.3171/2012.11.SPINE12111
    1. Klekamp J, Samii H. Surgical results for spinal metastases. Acta Neurochir (Wien). (1998) 140:957–67. 10.3171/2016.6.FOCUS16166
    1. Itshayek E, Yamada J, Bilsky M, Schmidt M, Shaffrey C, Gerszten P, et al. . Timing of surgery and radiotherapy in the management of metastatic spine disease: a systematic review. Int J Oncol. (2010) 36:533–44. 10.21037/jss.2018.05.05
    1. Tseng C-L, Eppinga W, Charest-Morin R, Soliman H, Myrehaug S, Maralani PJ, et al. . Spine stereotactic body radiotherapy: indications, outcomes, and points of caution. Glob Spine J. (2017) 7:179–97. 10.1177/2192568217694016
    1. Al-Omair A, Masucci L, Masson-Cote L, Campbell M, Atenafu EG, Parent A, et al. . Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy. Neuro-Oncol. (2013) 15:1413–9. 10.1093/neuonc/not101
    1. Hyde D, Lochray F, Korol R, Davidson M, Wong CS, Ma L, et al. . Spine stereotactic body radiotherapy utilizing cone-beam CT image-guidance with a robotic couch: intrafraction motion analysis accounting for all six degrees of freedom. Int J Radiat Oncol Biol Phys. (2012) 82:e555–62. 10.1016/j.ijrobp.2011.06.1980
    1. Tseng C-L, Sussman MS, Atenafu EG, Letourneau D, Ma L, Soliman H, et al. . Magnetic resonance imaging assessment of spinal cord and cauda equina motion in supine patients with spinal metastases planned for spine stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. (2015) 91:995–1002. 10.1016/j.ijrobp.2014.12.037
    1. Yenice KM, Lovelock DM, Hunt MA, Lutz WR, Fournier-Bidoz N, Hua C-H, et al. . CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization. Int J Radiat Oncol Biol Phys. (2003) 55:583–93. 10.1227/01.NEU.0000279970.10309.B5
    1. Li W, Sahgal A, Foote M, Millar B-A, Jaffray DA, Letourneau D. Impact of immobilization on intrafraction motion for spine stereotactic body radiotherapy using cone beam computed tomography. Int J Radiat Oncol Biol Phys. (2012) 84:520–6. 10.1016/j.ijrobp.2011.12.039
    1. Finnigan R, Lamprecht B, Barry T, Jones K, Boyd J, Pullar A, et al. . Inter- and intra-fraction motion in stereotactic body radiotherapy for spinal and paraspinal tumours using cone-beam CT and positional correction in six degrees of freedom. J Med Imaging Radiat Oncol. (2016) 60:112–8. 10.1111/1754-9485.12353
    1. Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, et al. . International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. (2012) 83:e597–605. 10.1016/j.ijrobp.2012.03.009
    1. Chan MW, Thibault I, Atenafu EG, Yu E, John Cho BC, Letourneau D, et al. . Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation. J Neurosurg Spine. (2016) 24:652–9. 10.3171/2015.6.SPINE15294
    1. Redmond KJ, Robertson S, Lo SS, Soltys SG, Ryu S, McNutt T, et al. . Consensus contouring guidelines for postoperative stereotactic body radiation therapy for metastatic solid tumor malignancies to the spine. Int J Radiat Oncol Biol Phys. (2017) 97:64–74. 10.1016/j.ijrobp.2016.09.014
    1. Faruqi S, Tseng C-L, Whyne C, Alghamdi M, Wilson J, Myrehaug S, et al. . Vertebral compression fracture after spine stereotactic body radiation therapy: a review of the pathophysiology and risk factors. Neurosurgery. (2018) 83:314–22. 10.1093/neuros/nyx493
    1. Redmond KJ, Sahgal A, Foote M, Knisely J, Gerszten PC, Chao ST, et al. . Single versus multiple session stereotactic body radiotherapy for spinal metastasis: the risk-benefit ratio. Future Oncol Lond Engl. (2015) 11:2405–15. 10.2217/fon.15.160
    1. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. . Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. (2010) 37:4078–101. 10.1118/1.3438081
    1. Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang U-K, et al. . Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. (2012) 82:107–16. 10.1016/j.ijrobp.2010.08.021
    1. Sahgal A, Ma L, Gibbs I, Gerszten PC, Ryu S, Soltys S, et al. . Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. (2010) 77:548–53. 10.1016/j.ijrobp.2009.05.023
    1. Chang EL, Shiu AS, Lii M-F, Rhines LD, Mendel E, Mahajan A, et al. . Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys. (2004) 59:1288–94. 10.1016/j.ijrobp.2004.04.025
    1. Degen JW, Gagnon GJ, Voyadzis J-M, McRae DA, Lunsden M, Dieterich S, et al. . CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. J Neurosurg Spine. (2005) 2:540–9. 10.3171/spi.2005.2.5.0540
    1. Amini B, Beaman CB, Madewell JE, Allen PK, Rhines LD, Tatsui CE, et al. . Osseous pseudoprogression in vertebral bodies treated with stereotactic radiosurgery: a secondary analysis of prospective phase I/II clinical trials. AJNR Am J Neuroradiol. (2016) 37:387–92. 10.3174/ajnr.A4528
    1. Bahig H, Simard D, Létourneau L, Wong P, Roberge D, Filion E, et al. . A study of pseudoprogression after spine stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. (2016) 96:848–56. 10.1016/j.ijrobp.2016.07.034
    1. Jabehdar Maralani P, Winger K, Symons S, Machnowska M, Heyn C, Helmi A, et al. . Incidence and time of onset of osseous pseudoprogression in patients with metastatic spine disease from renal cell or prostate carcinoma after treatment with stereotactic body radiation therapy. Neurosurgery. (2018) 84:647–54. 10.1093/neuros/nyy075
    1. Thibault I, Chang EL, Sheehan J, Ahluwalia MS, Guckenberger M, Sohn M-J, et al. . Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol. (2015) 16:e595–603. 10.1016/S1470-2045(15)00166-7
    1. Chow E, Hoskin P, Mitera G, Zeng L, Lutz S, Roos D, et al. . Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys. (2012) 82:1730–7. 10.1016/j.ijrobp.2011.02.008
    1. Amdur RJ, Bennett J, Olivier K, Wallace A, Morris CG, Liu C, et al. . A prospective, phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol. (2009) 32:515–20. 10.1097/COC.0b013e318194f70f
    1. Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu H-KG. Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. Int J Surg Oncol. (2011) 2011:979214. 10.1155/2011/979214
    1. Ghia AJ, Chang EL, Bishop AJ, Pan HY, Boehling NS, Amini B, et al. . Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. J Neurosurg Spine. (2016) 24:829–36. 10.3171/2015.8.SPINE15844
    1. Folkert MR, Bilsky MH, Tom AK, Oh JH, Alektiar KM, Laufer I, et al. . Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine. Int J Radiat Oncol Biol Phys. (2014) 88:1085–91. 10.1016/j.ijrobp.2013.12.042
    1. Gerszten PC, Burton SA, Quinn AE, Agarwala SS, Kirkwood JM. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact Funct Neurosurg. (2005) 83:213–21. 10.1159/000091952
    1. Tao R, Bishop AJ, Brownlee Z, Allen PK, Settle SH, Chang EL, et al. . Stereotactic body radiation therapy for spinal metastases in the postoperative setting: a secondary analysis of mature phase 1-2 trials. Int J Radiat Oncol Biol Phys. (2016) 95:1405–13.
    1. Redmond KJ, Lo SS, Fisher C, Sahgal A. Postoperative Stereotactic Body Radiation Therapy (SBRT) for spine metastases: a critical review to guide practice. Int J Radiat Oncol Biol Phys. (2016) 95:1414–28. 10.1016/j.ijrobp.2016.03.022
    1. Huisman M, van den Bosch MAAJ, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM. Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. (2012) 84:8–14. 10.1016/j.ijrobp.2011.10.080
    1. Myrehaug S, Sahgal A, Hayashi M, Levivier M, Ma L, Martinez R, et al. . Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J Neurosurg Spine. (2017) 27:428–35. 10.3171/2017.2.SPINE16976
    1. Hashmi A, Guckenberger M, Kersh R, Gerszten PC, Mantel F, Grills IS, et al. . Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. J Neurosurg Spine. (2016) 25:646–53. 10.1016/j.ijrobp.2016.06.301
    1. Chow E, Linden YM, van der Roos D, Hartsell WF, Hoskin P, Wu JSY, et al. . Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol. (2014) 15:164–71. 10.1016/S1470-2045(13)70556-4
    1. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine. (2007) 32:193–9. 10.1097/01.brs.0000251863.76595.a2
    1. Sprave T, Verma V, Förster R, Schlampp I, Bruckner T, Bostel T, et al. . Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. (2018) 128:274–82. 10.1016/j.radonc.2018.04.030
    1. Ryu S, Pugh SL, Gerszten PC, Yin F-F, Timmerman RD, Hitchcock YJ, et al. . RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol. (2014) 4:76–81. 10.1016/j.prro.2013.05.001
    1. Study, Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases - Full Text View - ClinicalTrials,.gov [Internet]. Available online at: (cited January 20, 2019).
    1. Guckenberger M, Wulf J, Mueller G, Krieger T, Baier K, Gabor M, et al. . Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys. (2009) 74:47–54. 10.1016/j.ijrobp.2008.06.1939
    1. Sprave T, Verma V, Förster R, Schlampp I, Bruckner T, Bostel T, et al. . Quality of life following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases: secondary analysis of an exploratory phase II randomized trial. Anticancer Res. (2018) 38:4961–8. 10.21873/anticanres
    1. Zeng KL, Myrehaug S, Soliman H, Tseng C-L, Atenafu EG, Campbell M, et al. . Stereotactic body radiotherapy for spinal metastases at the extreme ends of the spine: imaging-based outcomes for cervical and sacral metastases. Neurosurgery. (2018). [Epub ahead of print]. 10.1093/neuros/nyy393.
    1. Chow E, Meyer RM, Ding K, Nabid A, Chabot P, Wong P, et al. . Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol. (2015) 16:1463–72. 10.1016/S1470-2045(15)00199-0
    1. Balagamwala EH, Naik M, Reddy CA, Angelov L, Suh JH, Djemil T, et al. . Pain flare after stereotactic radiosurgery for spine metastases. J Radiosurgery SBRT. (2018) 5:99–105.
    1. Ryu S, Fang Yin F, Rock J, Zhu J, Chu A, Kagan E, et al. . Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer. (2003) 97:2013–8. 10.1002/cncr.11296
    1. Chiang A, Zeng L, Zhang L, Lochray F, Korol R, Loblaw A, et al. . Pain flare is a common adverse event in steroid-naïve patients after spine stereotactic body radiation therapy: a prospective clinical trial. Int J Radiat Oncol Biol Phys. (2013) 86:638–42. 10.1016/j.ijrobp.2013.03.022
    1. Khan L, Chiang A, Zhang L, Thibault I, Bedard G, Wong E, et al. . Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. (2015) 23:2937–43. 10.1007/s00520-015-2659-z
    1. Cunha MVR, Al-Omair A, Atenafu EG, Masucci GL, Letourneau D, Korol R, et al. . Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors. Int J Radiat Oncol Biol Phys. (2012) 84:e343–9. 10.1016/j.ijrobp.2012.04.034
    1. Rose PS, Laufer I, Boland PJ, Hanover A, Bilsky MH, Yamada J, et al. . Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol Off J Am Soc Clin Oncol. (2009) 27:5075–9. 10.1200/JCO.2008.19.3508
    1. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol Off J Am Soc Clin Oncol. (2007) 25:1423–36. 10.1016/j.clon.2011.11.004
    1. Sahgal A, Atenafu EG, Chao S, Al-Omair A, Boehling N, Balagamwala EH, et al. . Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol. (2013) 31:3426–31. 10.1200/JCO.2013.50.1411
    1. Lee S-H, Tatsui CE, Ghia AJ, Amini B, Li J, Zavarella SM, et al. . Can the spinal instability neoplastic score prior to spinal radiosurgery predict compression fractures following stereotactic spinal radiosurgery for metastatic spinal tumor?: a post hoc analysis of prospective phase II single-institution trials. J Neurooncol. (2016) 126:509–17. 10.1007/s11060-015-1990-z
    1. Thibault I, Whyne CM, Zhou S, Campbell M, Atenafu EG, Myrehaug S, et al. . Volume of lytic vertebral body metastatic disease quantified using computed tomography-based image segmentation predicts fracture risk after spine stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. (2017) 97:75–81. 10.1016/j.ijrobp.2016.09.029
    1. Sprave T, Verma V, Förster R, Schlampp I, Hees K, Bruckner T, et al. . Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial. BMC Cancer 18:859. 10.1186/s12885-018-4777-8
    1. Sahgal A, Weinberg V, Ma L, Chang E, Chao S, Muacevic A, et al. . Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys. (2013) 85:341–7. 10.1016/j.ijrobp.2012.05.00

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe